Verdence Capital Advisors LLC lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 534 shares of the semiconductor company’s stock after selling 33 shares during the quarter. Verdence Capital Advisors LLC’s holdings in Synopsys were worth $259,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Impax Asset Management Group plc boosted its stake in shares of Synopsys by 120.2% during the 3rd quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock valued at $248,497,000 after buying an additional 267,836 shares during the last quarter. Concurrent Investment Advisors LLC grew its holdings in Synopsys by 115.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 929 shares of the semiconductor company’s stock worth $471,000 after acquiring an additional 498 shares in the last quarter. M&G PLC increased its position in shares of Synopsys by 9.0% in the 3rd quarter. M&G PLC now owns 3,213 shares of the semiconductor company’s stock worth $1,626,000 after purchasing an additional 266 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of Synopsys by 1.1% in the 3rd quarter. Principal Financial Group Inc. now owns 247,966 shares of the semiconductor company’s stock valued at $125,568,000 after purchasing an additional 2,655 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS lifted its position in shares of Synopsys by 4.4% during the third quarter. Kornitzer Capital Management Inc. KS now owns 17,176 shares of the semiconductor company’s stock worth $8,698,000 after purchasing an additional 725 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares of the company’s stock, valued at approximately $32,890,077.50. This represents a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on SNPS
Synopsys Trading Up 1.2 %
Shares of NASDAQ:SNPS opened at $450.88 on Friday. The firm’s 50 day moving average is $501.21 and its two-hundred day moving average is $512.34. The firm has a market capitalization of $69.72 billion, a P/E ratio of 31.05, a PEG ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 52 week low of $429.77 and a 52 week high of $624.80.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What Are Treasury Bonds?
- Is Myers Industries Poised for a Breakout?
- How to Invest in the FAANG Stocks
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- What is Short Interest? How to Use It
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.